First National Bank of Omaha’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Buy
8,588
+32
+0.4% +$1.15K 0.01% 471
2026
Q1
$303K Sell
8,556
-446
-5% -$18.1K 0.01% 456
2025
Q4
$365K Buy
9,002
+2,484
+38% +$108K 0.01% 440
2025
Q3
$307K Buy
+6,518
New +$338K 0.02% 299
2014
Q4
Sell
-9,350
Closed -$344K 375
2014
Q3
$344K Hold
9,350
0.03% 328
2014
Q2
$413K Sell
9,350
-3,925
-30% -$178K 0.03% 318
2014
Q1
$577K Hold
13,275
0.04% 274
2013
Q4
$564K Sell
13,275
-275
-2% -$10.4K 0.04% 269
2013
Q3
$460K Buy
13,550
+2,975
+28% +$97.1K 0.04% 291
2013
Q2
$330 Buy
+10,575
New +$343K 0.03% 331

Other funds holding CNMD

First National Bank of Omaha's CNMD Position: Q2 2026 in Review

First National Bank of Omaha increased its CONMED (CNMD) stake by 0.37% in Q2 2026, buying an estimated $1.15K and bringing the position to 8,588 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #471.

First National Bank of Omaha first reported a position in CNMD in Q2 2013 and has held it in 10 quarters since. The position peaked at $577K in Q1 2014. 92 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • First National Bank of Omaha held 8,588 shares of CONMED worth $281K as of Q2 2026.
  • First National Bank of Omaha bought 32 CONMED shares in Q2 2026, an estimated $1.15K.
  • CONMED made up 0.01% of First National Bank of Omaha's portfolio in Q2 2026, its #471 holding.
  • First National Bank of Omaha first reported a position in CONMED in Q2 2013 and has held it in 10 quarters since.
  • First National Bank of Omaha's CONMED position peaked at $577K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on First National Bank of Omaha's 13F filing for Q2 2026, filed 7 Aug 2026.